Loading...

World-Class Retina Care. Community-Based Caring.

Dr. Abbey Contributes to Real-world Study of Faricimab for Neovascular Age-related Macular Degeneration

Posted On May 23, 2023 / By / Posted in Blog

Dr. Abbey Contributes to Real-world Study of Faricimab for Neovascular Age-related Macular Degeneration

The TRUCKEE study is a real-world, collaborative effort to investigate the efficacy, durability, and safety of a monoclonal antibody treatment called faricimab in patients suffering from neovascular age-related macular degeneration (nAMD) in

read more
Posted On August 24, 2021 / By / Posted in Blog

Dr. Abbey Reports on Five Emerging Treatments Presented at ARVO 2021

In the July/August 2021 issue of Retina Specialist, Texas Retina Associates’ Ashkan Abbey, MD, published highlights from five compelling retina presentations at the recent Association for Research in Vision and Ophthalmology (ARVO)

read more